Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Article
Moving claims forward during COVID-19 - Guidelines
In the face of a crisis, the workers’ comp community has historically pulled together to overcome whatever obstacle that’s come our way.
Workers' Comp
Article
Meeting Your Needs Through Hurricane Florence
As Hurricane Florence approaches the East Coast, we want you to know you will have access to Genex’s services at all times.
Mitchell
News Release
Impact of COVID-19 on Workers' Compensation and Auto Casualty Industries
Auto Casualty
Article
Five Questions With Shahin Hatamian on How to Incorporate More Automation in the Claims Process
We sat down with Mitchell Senior Vice President, Shahin Hatamian, to discuss how claims organizations can utilize automation to help expedite proce
Mitchell
News Release
State-By-State Pharmacy Rule Updates Related to COVID-19
In the wake of COVID-19, a number of states have begun relaxing time frames and other rules around the provision of care for their citizens, includ
Mitchell
Article
Impact of COVID-19 on Workers’ Compensation and Auto Casualty Industries
As the COVID-19 pandemic continues worldwide, our daily lives have changed significantly.